Post-Crisis, Switzerland Likely To ‘Repatriate’ BioPharm Manufacturing

Biotech Trade Head Foresees Rising 'Swiss Made' Trend

In a post-COVID-19 world, Switzerland’s thriving life sciences sector will be supported by increased domestic manufacturing and production capacity, a sector expert says.

Swiss_Made_Stamp
Swiss biotech and pharma exports already comprise 40% of the total • Source: Shutterstock

More from Business

More from Scrip